A study on MDMA treatment for new mothers, which launched in the spring, is being led by Dr. Larry Leeman, the medical director of the University of New Mexico’s Milagro Program. Leeman “treats ...

MDMA (3,4-methylenedioxymethamphetamine), known colloquially as Molly and Ecstasy, is a synthetic drug with effects similar to stimulants like methamphetamine. It was first synthesized in 1912 by ...

A panel of advisers to the U.S. Food and Drug Administration will meet to discuss a therapy based on the psychedelic drug MDMA for patients with post-traumatic stress disorder. The meeting is the ...

Psilocybin (the active ingredient of magic mushrooms) and MDMA (the active ingredient in ecstasy) are psychedelic or hallucinogenic drugs that can change how a person sees things and feels. In 2023, ...

WASHINGTON — A first-of-a-kind proposal to begin using the mind-altering drug MDMA as a treatment for PTSD was roundly criticized Tuesday — a potentially major setback to psychedelic advocates who ...

Follow this section to personalize your feed and get instant alerts. WHY FOLLOW? Update your preferences in Account Settings Personalized Content Follow this tag to personalize your feed and get ...

FILE - In this photo made with a long exposure, a man is silhouetted against lights reflected in the waters off Cape Neddick in Maine on Dec. 11, 2017. Federal health advisers are considering the ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. The Department of Veterans Affairs (VA) announced on Tuesday that it ...

The MDMA study was her last hope. She had read headlines celebrating a 83% response rate in one small, early study of the psychedelic for treating PTSD, and was counting on the new clinical trial to ...

Federal health advisers are weighing the first-of-a-kind approval of MDMA, the mind-altering club drug, as a treatment for PTSD—part of a decadeslong effort by psychedelic advocates to win medical ...